A Crohn's Disease Patient Who Does Not Respond to Infliximab: What Is Next?

被引：5
|
作者：
Maharshak, Nitsan [1 ]
Plevy, Scott E. [1 ]
机构：
[1] Univ N Carolina, Sch Med, Div Gastroenterol & Hepatol, Dept Med,Inflammatory Bowel Dis Ctr, Chapel Hill, NC USA
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2011年 / 9卷 / 12期
关键词：
NECROSIS-FACTOR-ALPHA; MONOCLONAL-ANTIBODY; THERAPY; ASSOCIATION; TERM; GASTROENTEROLOGY; NATALIZUMAB; INDUCTION; EFFICACY; MODERATE;
D O I：
10.1016/j.cgh.2011.05.027
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1033 / 1038
页数：6
相关论文
共 50 条
  • [21] Infliximab in Crohn's disease
    Sáez, LR
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2004, 96 (06) : 359 - 363
  • [22] Infliximab for Crohn's disease
    Verspaget, HW
    van der Zon, AM
    Gao, Q
    van Hogezand, RA
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (12) : 2041 - 2042
  • [23] Extra-intestinal manifestations of Crohn disease respond to infliximab
    Parsi, MA
    Achkar, JP
    Brzezinski, A
    Shen, B
    Lashner, B
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S265 - S265
  • [24] Does smoking reduce infliximab's effectiveness against Crohn's disease?
    Narula, Neeraj
    Fedorak, Richard N.
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 23 (02) : 121 - 125
  • [25] INFLIXIMAB (IFX) DOES NOT ALTER ILEOCECTOMY FOR CROHN'S DISEASE (CD)
    Messaris, E.
    Sehgal, R.
    Koltun, W.
    Stewart, D.
    McKenna, K.
    Poritz, L.
    DISEASES OF THE COLON & RECTUM, 2011, 54 (05) : E106 - E106
  • [26] Does infliximab favourably affect growth in paediatric Crohn's disease?
    Hill, R. J.
    Lewindon, P. J.
    Ee, L. C.
    Withers, G. D.
    Connor, F. L.
    Grange, I.
    Cleghorn, G. J.
    Davies, P. S. W.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A313 - A313
  • [27] Does Smoking Decrease the Response to Infliximab in Patients with Crohn's Disease?
    Parsi, Mansour A.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 : S18 - S19
  • [28] What Is the Rate of Loss of Response to Infliximab Therapy in Crohn's Disease?
    Chao, Jingdong
    Mulani, Parvez
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (09): : 2353 - 2354
  • [29] Adalimumab for orbital myositis in a patient with Crohn’s disease who discontinued infliximab: a case report and review of the literature
    Sanam Verma
    Karen I Kroeker
    Richard N Fedorak
    BMC Gastroenterology, 13
  • [30] Certolizumnab pegol treatment of Crohn's disease in a patient who had an adverse reaction to infliximab: A case report
    Sedlak, Markus
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S367 - S367
12345